Unity Biotechnology Valuation
| UBXDelisted Stock | USD 0.16 0.01 6.67% |
Unity Biotechnology seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Unity Biotechnology from inspecting the company fundamentals such as Shares Outstanding of 17.21 M, return on equity of -2.31, and Shares Owned By Institutions of 17.10 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Unity Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of Unity Biotechnology is based on 3 months time horizon. Increasing Unity Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Unity Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Unity Stock. However, Unity Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.16 | Real 0.15 | Hype 0.16 |
The intrinsic value of Unity Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Unity Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Unity Biotechnology helps investors to forecast how Unity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Unity Biotechnology more accurately as focusing exclusively on Unity Biotechnology's fundamentals will not take into account other important factors: Unity Biotechnology Total Value Analysis
Unity Biotechnology is at this time forecasted to have company total value of 3.53 M with market capitalization of 3.44 M, debt of 23.54 M, and cash on hands of 64.51 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Unity Biotechnology fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.53 M | 3.44 M | 23.54 M | 64.51 M |
Unity Biotechnology Asset Utilization
One of the ways to look at asset utilization of Unity is to check how much profit was generated for every dollar of assets it reports. Unity Biotechnology has a negative utilization of assets of -0.39 %, losing $0.003889 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Unity Biotechnology shows how discouraging it operates for each dollar spent on its assets.Unity Biotechnology Ownership Allocation
Unity Biotechnology shows a total of 17.21 Million outstanding shares. About 81.0 % of Unity Biotechnology outstanding shares are held by general public with 1.9 (%) owned by insiders and only 17.1 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Unity Biotechnology Profitability Analysis
Reported Net Loss for the year was (25.99 M) with loss before taxes, overhead, and interest of (12.06 M).About Unity Biotechnology Valuation
Our relative valuation model uses a comparative analysis of Unity Biotechnology. We calculate exposure to Unity Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Unity Biotechnology's related companies.Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. Unity Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Unity Stock
If you are still planning to invest in Unity Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Unity Biotechnology's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |